Partners Value Investments L.P.Partners Value Investments L.P.

Institutional investor · Portfolio as of Q3 2023

SEC EDGAR SourceSEC Filings

Top Holdings10 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

BROOKFIELD CORP /CAD/

133.7M$4.2B78.5%$20.540.00%
1 qtr
New
100

BROOKFIELD ASSET MGMT-A-W/I

30.5M$1B19.1%$30.910.00%
1 qtr
New
100
BBUBBU
Unit

BROOKFIELD BUSINESS PARTNERS

2.9M$44.4M0.8%$14.89-0.03%
19 qtrssince 2017-Q1
Increased
69
915,000$28.8M0.5%
New
59
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

194,375$16.9M0.3%$82.380.00%
1 qtr
New
50

BROOKFIELD BUSINESS CORP

747,734$13.5M0.3%$17.700.00%
1 qtr
New
49
SHYGSHYG
ETF

ISHARES TR

241,302$9.9M0.2%$30.72+12.94%
6 qtrssince 2020-Q2
Unchanged
0
MPLXMPLX
Unit

MPLX LP

160,500$5.7M0.1%$28.980.00%
1 qtr
New
48
LQDLQD
ETF

ISHARES IBOXX INVESTMENT GRA

36,515$3.7M0.1%$110.71-17.23%
5 qtrssince 2020-Q3
Unchanged
0

AT&T INC

219,000$3.3M0.1%$13.130.00%
1 qtr
New
40
$5.3B
AUM
10
Positions
Q3 2023
Filing
Rating · 3.5
Quarterly Portfolio Change
+6%Q2'17$627.6M+7%Q3'17$673.3M-0%Q4'17$671.6M+448%Q1'18$3.7B+3%Q2'18$3.8B+40%Q3'23$5.3B
Activity profile
$ moved · Q3'23
New0%Increased0%Decreased0%Exited100%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 years
<1Q70%1-4Q0%1-2Y0%2Y+30%

Partners Value Investments L.P. manages $5.3B across 10 positions as of Q3 2023. Top holdings: BN (78.5%), BAM (19.1%), BBU (0.8%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 3.5/5.0.

Q3 2023 Summary

Active quarter - 7 new positions, 5 exits, 1 increased. Top move: BN (NEW, conviction 100). Portfolio: $5.3B across 10 positions.

Top holdings by portfolio weight

Total AUM$5B
BN78.52%
BAM19.11%
BBU0.83%
BROOKFIELD R0.54%
BABA0.32%
BBUC0.25%
SHYG0.19%
MPLX0.11%
LQD0.07%
T0.06%

Portfolio allocation by GICS sector

Sectors5
Financial Services98.42%
Industrials0.84%
Unknown0.37%
Consumer Cyclical0.32%
Communication Services0.06%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record74
Conviction40
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used